TY - JOUR AU - Wagstaff, J. PY - 2007 DA - 2007// TI - Renal cell cancer: is immunotherapy dead? JO - Ann Oncol VL - 18 ID - Wagstaff2007 ER - TY - JOUR AU - Miyake, M. AU - Anai, S. AU - Fujimoto, K. PY - 2012 DA - 2012// TI - 5-fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma JO - Oncol Lett VL - 3 ID - Miyake2012 ER - TY - JOUR AU - Miyake, M. AU - Fujimoto, K. AU - Tanaka, M. PY - 2009 DA - 2009// TI - Immunochemotherapy with interferon-α, interleukin-2, 5-fluorouracil, and cimetidine for patients with advanced renal cell carcinoma JO - J Nara Med Assoc VL - 60 ID - Miyake2009 ER - TY - JOUR AU - Escudier, B. AU - Albiges, L. AU - Blesius, A. PY - 2010 DA - 2010// TI - How to select targeted therapy in renal cell cancer JO - Ann Oncol VL - 21 ID - Escudier2010 ER - TY - JOUR AU - Motzer, R. J. AU - Hutson, T. E. AU - Tomczak, P. PY - 2009 DA - 2009// TI - Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.1293 DO - 10.1200/JCO.2008.20.1293 ID - Motzer2009 ER - TY - JOUR AU - Motzer, R. J. AU - Rini, B. I. AU - Bukowski, R. M. PY - 2006 DA - 2006// TI - Sunitinib in patients with metastatic renal cell carcinoma JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.21.2516 DO - 10.1001/jama.295.21.2516 ID - Motzer2006 ER - TY - JOUR AU - Dutcher, J. P. PY - 2013 DA - 2013// TI - Recent developments in the treatment of renal cell carcinoma JO - Ther Adv Urol VL - 5 UR - https://doi.org/10.1177/1756287213505672 DO - 10.1177/1756287213505672 ID - Dutcher2013 ER - TY - JOUR AU - Seidel, C. AU - Busch, J. AU - Weikert, S. PY - 2012 DA - 2012// TI - Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2012.02.048 DO - 10.1016/j.ejca.2012.02.048 ID - Seidel2012 ER - TY - JOUR AU - Abel, E. J. AU - Culp, S. H. AU - Tannir, N. M. PY - 2011 DA - 2011// TI - Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib JO - Eur Urol VL - 60 UR - https://doi.org/10.1016/j.eururo.2011.07.008 DO - 10.1016/j.eururo.2011.07.008 ID - Abel2011 ER - TY - JOUR AU - Jain, R. K. AU - Lee, J. J. AU - Ng, C. PY - 2012 DA - 2012// TI - Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studies JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.36.4752 DO - 10.1200/JCO.2011.36.4752 ID - Jain2012 ER - TY - JOUR AU - Molina, A. M. AU - Zhang, J. AU - Lin, X. PY - 2012 DA - 2012// TI - Sunitinib objective response (OR) in metastatic renal cell carcinoma (mRCC): analysis of 1,059 patients treated on clinical trials JO - ASCO Meet Abstr VL - 30 ID - Molina2012 ER - TY - STD TI - Grunwald V, Seidel C, Fenner M, et al. Use of early tumor shrinkage as a response to VEGF inhibitors as a predictor of progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC). J Clin Oncol. 2012;30 Suppl:abstract 4631. ID - ref12 ER - TY - JOUR AU - Busch, J. AU - Seidel, C. AU - Goranova, I. PY - 2014 DA - 2014// TI - Categories of response to first line vascular endothelial growth factor receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma JO - Eur J Cancer VL - 50 UR - https://doi.org/10.1016/j.ejca.2013.10.017 DO - 10.1016/j.ejca.2013.10.017 ID - Busch2014 ER - TY - JOUR AU - Heng, D. Y. AU - Xie, W. AU - Regan, M. M. PY - 2009 DA - 2009// TI - Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.4809 DO - 10.1200/JCO.2008.21.4809 ID - Heng2009 ER - TY - JOUR AU - Naito, S. AU - Yamamoto, N. AU - Takayama, T. PY - 2010 DA - 2010// TI - Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients JO - Eur Urol VL - 57 UR - https://doi.org/10.1016/j.eururo.2008.12.026 DO - 10.1016/j.eururo.2008.12.026 ID - Naito2010 ER - TY - JOUR AU - Schutz, F. A. AU - Xie, W. AU - Donskov, F. PY - 2014 DA - 2014// TI - The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium JO - Eur Urol VL - 65 UR - https://doi.org/10.1016/j.eururo.2013.10.013 DO - 10.1016/j.eururo.2013.10.013 ID - Schutz2014 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Choi, H. AU - Charnsangavej, C. AU - Faria, S. C. PY - 2007 DA - 2007// TI - Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.07.3049 DO - 10.1200/JCO.2006.07.3049 ID - Choi2007 ER - TY - JOUR AU - Seidel, C. AU - Busch, J. AU - Weikert, S. PY - 2013 DA - 2013// TI - Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC) JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.662 DO - 10.1038/bjc.2013.662 ID - Seidel2013 ER - TY - JOUR AU - Veldt, A. A. AU - Meijerink, M. R. AU - Eertwegh, A. J. PY - 2010 DA - 2010// TI - Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib JO - Br J Cancer VL - 102 UR - https://doi.org/10.1038/sj.bjc.6605567 DO - 10.1038/sj.bjc.6605567 ID - Veldt2010 ER - TY - JOUR AU - Smith, A. D. AU - Lieber, M. L. AU - Shah, S. N. PY - 2010 DA - 2010// TI - Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT JO - AJR Am J Roentgenol VL - 194 UR - https://doi.org/10.2214/AJR.09.2941 DO - 10.2214/AJR.09.2941 ID - Smith2010 ER - TY - JOUR AU - Smith, A. D. AU - Shah, S. N. AU - Rini, B. I. PY - 2010 DA - 2010// TI - Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy JO - AJR Am J Roentgenol VL - 194 UR - https://doi.org/10.2214/AJR.09.3456 DO - 10.2214/AJR.09.3456 ID - Smith2010 ER - TY - JOUR AU - Motzer, R. J. AU - Bacik, J. AU - Murphy, B. A. PY - 2002 DA - 2002// TI - Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.20.1.289 DO - 10.1200/JCO.20.1.289 ID - Motzer2002 ER - TY - JOUR AU - Heng, D. Y. AU - Xie, W. AU - Regan, M. M. PY - 2013 DA - 2013// TI - External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(12)70559-4 DO - 10.1016/S1470-2045(12)70559-4 ID - Heng2013 ER - TY - JOUR AU - Szmit, S. AU - Langiewicz, P. AU - Złnierek, J. PY - 2012 DA - 2012// TI - Hypertension as a predictive factor for survival outcomes in patients with metastatic renal cell carcinoma treated with sunitinib after progression on cytokines JO - Kidney Blood Press Res VL - 35 UR - https://doi.org/10.1159/000329933 DO - 10.1159/000329933 ID - Szmit2012 ER - TY - JOUR AU - Fiore, F. AU - Rigal, O. AU - Ménager, C. PY - 2011 DA - 2011// TI - Severe clinical toxicities are correlated with survival in patients with advanced renal cell carcinoma treated with sunitinib and sorafenib JO - Br J Cancer VL - 105 UR - https://doi.org/10.1038/bjc.2011.507 DO - 10.1038/bjc.2011.507 ID - Fiore2011 ER - TY - JOUR AU - Bono, P. AU - Elfving, H. AU - Utriainen, T. PY - 2009 DA - 2009// TI - Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn729 DO - 10.1093/annonc/mdn729 ID - Bono2009 ER - TY - STD TI - Rini BI, Schiller JH, Fruehauf JP, et al. Association of diastolic blood pressure 190 mm Hg with overall survival in patients treated with axitinib. J Clin Oncol. 2008; 26:15S, abstr 3543. ID - ref28 ER - TY - JOUR AU - Sire, M. AU - Wallerand, H. AU - Kilkoski, F. PY - 2008 DA - 2008// TI - Anti-angiogenic treatment in the management of metastatic renal cell carcinoma JO - Bull Cancer VL - 95 ID - Sire2008 ER -